IDXX - IDEXX Laboratories, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
289.85
+5.12 (+1.80%)
At close: 4:00PM EDT

289.85 0.00 (0.00%)
After hours: 4:53PM EDT

Stock chart is not supported by your current browser
Previous Close284.73
Open283.36
Bid288.50 x 1400
Ask289.96 x 900
Day's Range283.36 - 290.37
52 Week Range176.11 - 290.37
Volume360,690
Avg. Volume415,861
Market Cap24.929B
Beta (3Y Monthly)1.21
PE Ratio (TTM)65.58
EPS (TTM)4.42
Earnings DateAug 1, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est277.20
Trade prices are not sourced from all markets
  • PR Newswire8 hours ago

    IDEXX Laboratories Elects Sam Samad to Board of Directors

    WESTBROOK, Maine , July 18, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, announced ...

  • Markit3 days ago

    See what the IHS Markit Score report has to say about Idexx Laboratories Inc.

    Idexx Laboratories Inc NASDAQ/NGS:IDXXView full report here! Summary * Bearish sentiment is low * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is extremely low for IDXX with fewer than 1% of shares on loan. This could indicate that investors who seek to profit from falling equity prices are not currently targeting IDXX. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold IDXX had net inflows of $8.81 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • PR Newswire4 days ago

    IDEXX Laboratories to Release 2019 Second Quarter Financial Results

    WESTBROOK, Maine , July 15, 2019 /PRNewswire/ --  IDEXX Laboratories, Inc.  (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, has scheduled ...

  • Who Has Been Selling IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares?
    Simply Wall St.9 days ago

    Who Has Been Selling IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares?

    We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...

  • S&P 500 index tops 3,000 for first time — here’s how the stock market got here and what it means
    MarketWatch9 days ago

    S&P 500 index tops 3,000 for first time — here’s how the stock market got here and what it means

    Five years in the making. That is essentially the time it has taken for the S&P 500 to hit a milestone mark at 3,000 for the first time in its history. The stock gauge first closed at 2,000 on Aug. 26, 2014, according to Dow Jones Market Data.

  • PR Newswire18 days ago

    IDEXX Laboratories Chairman, President and Chief Executive Officer, Jonathan Ayers, Taking Medical Leave of Absence

    WESTBROOK, Maine, July 1, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, today announced that Chairman, President and Chief Executive Officer, Jonathan Ayers, is on a medical leave of absence following a serious bicycling accident that occurred on June 27, 2019. Effective June 28, 2019, the IDEXX Board of Directors has appointed Jay Mazelsky as Interim President and Chief Executive Officer.

  • Motley Fool21 days ago

    4 Lower-Risk Healthcare Picks for Long-Term Investors

    The Healthcare and Wealthcare basket gets investors a diversified and pretty darn safe entry to what can be a very volatile market.

  • The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS
    Zacks22 days ago

    The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS

    The Zacks Analyst Blog Highlights: Merck, Tractor Supply, IDEXX and CVS

  • 4 Stocks to Make the Most of the Growing Love for Pets
    Zacks23 days ago

    4 Stocks to Make the Most of the Growing Love for Pets

    With the U.S. pet industry poised to grow 3.9% to a record $75.4 billion this year, here are few stocks that could gain from the growing love for animals.

  • 2 Stocks to Play the Pet Care Trend
    Motley Fool25 days ago

    2 Stocks to Play the Pet Care Trend

    With consumers spending as much as $72 billion on their pets in 2018, here are 2 companies that could benefit most from our love of animals.

  • IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength
    Zacks28 days ago

    IDEXX (IDXX) Gains Traction From Solid CAG, Global Strength

    IDEXX (IDXX) consistently benefits from strong organic growth, driven by robust sales at the CAG business, fueled by a firm global Catalyst adoption.

  • Near-Term Outlook for Medical Instruments Industry Bleak
    Zacks28 days ago

    Near-Term Outlook for Medical Instruments Industry Bleak

    Near-Term Outlook for Medical Instruments Industry Bleak

  • Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Pay Matter?
    Simply Wall St.last month

    Does IDEXX Laboratories, Inc.'s (NASDAQ:IDXX) CEO Pay Matter?

    Jon Ayers became the CEO of IDEXX Laboratories, Inc. (NASDAQ:IDXX) in 2002. First, this article will compare CEO...

  • Were Hedge Funds Right About Flocking Into IDEXX Laboratories, Inc. (IDXX) ?
    Insider Monkeylast month

    Were Hedge Funds Right About Flocking Into IDEXX Laboratories, Inc. (IDXX) ?

    The government requires hedge funds and wealthy investors that crossed the $100 million equity holdings threshold are required to file a report that shows their positions at the end of every quarter. Even though it isn't the intention, these filings level the playing field for ordinary investors. The latest round of 13F filings disclosed the […]

  • Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?
    Zacks2 months ago

    Why Is Idexx (IDXX) Up 3% Since Last Earnings Report?

    Idexx (IDXX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now
    Zacks2 months ago

    Here's Why You Should Invest in IDEXX Laboratories (IDXX) Now

    IDEXX (IDXX) registers strong revenue growth on the back of CAG Diagnostics.

  • TheStreet.com2 months ago

    Idexx Labs Could Be Forming a Double Top or Just Pausing in an Uptrend

    For his Executive Decision segment of "Mad Money" Wednesday our own Jim Cramer sat down with Jonathan Ayers, chairman, president and CEO of Idexx Laboratories Inc. IDXX, an animal health company. For those pets who do see their vet, however, diagnostics from Idexx are becoming an integral part of their care. Ayers said Idexx continues to innovate, which helps it see strong organic growth and increased operating margins.

  • CNBC2 months ago

    Idexx Labs is counting on millennials to boost the pet-care industry

    "[Millennials] are more likely to go to the vet more frequently and more willing to listen to an advanced standard of care," CEO Jonathan Ayers says. About 42% of millennials think their pets have special health needs — more than double the percentage of the baby boomer generation, he said. Idexx Laboratories IDXX has room to grow in providing preventative care for pets, CEO Jonathan Ayers told CNBC Wednesday.

  • GuruFocus.com2 months ago

    Baron Capital Commentary: 3 Opportunities in the Animal Health Space

    By Portfolio Manager Neal Rosenberg: How the 'humanization' of pets has created a booming industry

  • PR Newswire2 months ago

    IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences

    WESTBROOK, Maine , May 20, 2019 /PRNewswire/ -- IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing, will participate ...

  • Should You Like IDEXX Laboratories, Inc.’s (NASDAQ:IDXX) High Return On Capital Employed?
    Simply Wall St.2 months ago

    Should You Like IDEXX Laboratories, Inc.’s (NASDAQ:IDXX) High Return On Capital Employed?

    Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift...